Methylprednisolone Completed Phase 4 Trials for Immunosuppression Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02953873Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients